"TcLand Expression - Product Pipeline Analysis, 2013 Update" Is Now Available at Fast Market Research
TcLand Expression (TcLand) is a biotechnology company. The company develops companion diagnostics (CDx) in immune mediated disorders and biomarkers in solid organ transplantation. Its research and development platform develops, and validates invasive multi-genes molecular diagnostic blood tests. TcLand's clinical development programs include RA-INF-Dx Test, and L-TolX test. The company's research and development process alsdo combines biological process with data driven approaches. It has strategic alliance with Val d'Hebron Hospital, Hospital Clinic Barcelona, Institut National de la Recherche Medicale, and IMI...
View full press release